| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |